These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2604892)

  • 1. [The effectiveness of the hypolipemic preparation lovastatin in patients with ischemic heart disease and hyperlipoproteinemia].
    Iurenev AP; Zhukova IM; Lediashova GA; Kiseleva OA; Pomerantsev EV
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1989; 12(2):71-4. PubMed ID: 2604892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of lovastatin therapy on the dynamics of the clinical state of patients with ischemic heart disease and hyperlipoproteinemia].
    Zhukova IM; Iurenev AP; Pomerantsev EV; Martynov AA; Shabalkin BV; Titov VN; Shimbaeva NA; Kotkina AA; Bochkova EI; Lediashova GA
    Ter Arkh; 1990; 62(8):130-3. PubMed ID: 2274859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Influence of lovastatin on serum lipids in patients with primary hyperlipidemia phenotype IIa and IIb. I. Efficacy of lovastatin in the treatment of hyperlipoproteinemia].
    Idzior-Waluś B
    Przegl Lek; 1992; 49(9):287-91. PubMed ID: 1302351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose effect of simvastatin (MK-733) on serum lipids, lipoproteins, and apolipoproteins in patients with hypercholesterolemia.
    Saku K; Sasaki J; Arakawa K
    Clin Ther; 1989; 11(2):247-57. PubMed ID: 2736571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effects of lovastatin and niacin in primary hypercholesterolemia. A prospective trial.
    Illingworth DR; Stein EA; Mitchel YB; Dujovne CA; Frost PH; Knopp RH; Tun P; Zupkis RV; Greguski RA
    Arch Intern Med; 1994 Jul; 154(14):1586-95. PubMed ID: 8031206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lipanor treatment of atherogenic hyperlipoproteinemia].
    Susekov AV; Tvorogova MG; Arabidze GG; Kukharchuk VV
    Ter Arkh; 1998; 70(9):57-61. PubMed ID: 9821228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lovastatin efficacy and tolerance in primary hypercholesterolemia. The German Lovastatin Study Group].
    Thiery J; Basten A; Sommerburg C; Seidel D
    Dtsch Med Wochenschr; 1991 Jun; 116(23):887-94. PubMed ID: 2040207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of lovastatin (20-80 mg daily) on lipoprotein fractions in patients with severe primary hypercholesterolemia.
    März W; Grützmacher P; Paul D; Siekmeier R; Schoeppe W; Gross W
    Int J Clin Pharmacol Ther; 1994 Feb; 32(2):92-7. PubMed ID: 8004365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Multicenter comparative study on safety, tolerance, and effectiveness of lovastatin combined or not with cholestyramine, and gemfibrozil combined or not with cholestyramine in the treatment of primary hypercholesterolemia].
    Jover E; Aranda JL; Nogués X; del Palacio A; Rubiés-Prat J
    Med Clin (Barc); 1996 May; 106(20):776-9. PubMed ID: 8801396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of policosanol and lovastatin on lipid profile and lipid peroxidation in patients with dyslipidemia associated with type 2 diabetes mellitus.
    Castaño G; Menéndez R; Más R; Amor A; Fernández JL; González RL; Lezcay M; Alvarez E
    Int J Clin Pharmacol Res; 2002; 22(3-4):89-99. PubMed ID: 12837046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein abnormalities and extracoronary atherosclerosis in patients with premature ischemic heart disease.
    Rubba P; Faccenda F; Iorio D; Pauciullo P; Cortese C; Spampinato N; Mancini M
    Int Angiol; 1987; 6(4):331-7. PubMed ID: 3330114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of lovastatin on serum lipids and lipoproteins. Hungarian multicenter, open-label study].
    Romics L; Karádi I; Csanády M; Gógl A; Jánosi A; Ofner P; Tarján J; Varga L; Wórum F; Zeltner G
    Orv Hetil; 1994 Oct; 135(40):2187-91. PubMed ID: 7970631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of lovastatin on serum lipids in patients with nonfamilial primary hypercholesterolemia.
    Itskovitz HD; Flamenbaum W; De Gaetano C; Pritchard KA; Stemerman MB
    Clin Ther; 1989; 11(6):862-72. PubMed ID: 2611825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trial.
    Derosa G; Cicero AE; Bertone G; Piccinni MN; Ciccarelli L; Roggeri DE
    Clin Ther; 2004 Oct; 26(10):1599-607. PubMed ID: 15598476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical research on the hypolipidemic action of a probucol preparation].
    Naumova R; Kerekovska M; Goranov I; Balabanski L
    Vutr Boles; 1986; 25(2):73-7. PubMed ID: 3716382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effective long-term treatment of primary hyperlipoproteinemias with bezafibrate].
    Schiffl H; Weidmann P; Fragiacomo C; Noseda G; Bachmann C
    Schweiz Med Wochenschr; 1985 Jun; 115(26):907-11. PubMed ID: 3927481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholesterol-lowering therapy after heart transplantation: a 12-month randomized trial.
    Pflugfelder PW; Huff M; Oskalns R; Rudas L; Kostuk WJ
    J Heart Lung Transplant; 1995; 14(4):613-22. PubMed ID: 7578166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes in serum lipid levels, lipid composition and lipoprotein fractions in patients with ischemic cardiopathies or arterial hypertension].
    Dakovska L; Orbetzov M; Orbetzova V; Yarovska N
    Paroi Arterielle; 1981; 7(1):15-22. PubMed ID: 7339537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the short term efficacy and tolerability of lovastatin and simvastatin in the management of primary hypercholesterolemia.
    Frohlich J; Brun LD; Blank D; Campeau L; Crockford P; Curnew G; Dafoe W; Davignon J; Dufour R; Emery G
    Can J Cardiol; 1993 Jun; 9(5):405-12. PubMed ID: 8348392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of severe, resistant familial combined hyperlipidemia with a bezafibrate-lovastatin combination.
    Yeshurun D; Abukarshin R; Elias N; Lanir A; Naschitz JE
    Clin Ther; 1993; 15(2):355-63. PubMed ID: 8519043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.